Phase II Clinical Development of New Drugs von Naitee Ting | ISBN 9789811041945

Phase II Clinical Development of New Drugs

von Naitee Ting, Ding-Geng Chen, Shuyen Ho und Joseph C. Cappelleri
Mitwirkende
Autor / AutorinNaitee Ting
Autor / AutorinDing-Geng Chen
Autor / AutorinShuyen Ho
Autor / AutorinJoseph C. Cappelleri
Buchcover Phase II Clinical Development of New Drugs | Naitee Ting | EAN 9789811041945 | ISBN 981-10-4194-6 | ISBN 978-981-10-4194-5
“It provides a hands-on approach to each subject, and the necessary statistical background is presented in the most non-mathematical way possible. … Throughout the book, the scope of each subject is well defined, and if the reader has the need for further support, useful references are helpfully recommended. … I would strongly recommend this book to anyone working in clinical development or with an interest in this field, regardless of their background.” (David Manteigas, ISCB News, iscb. info, Issue 65, June, 2018)

Phase II Clinical Development of New Drugs

von Naitee Ting, Ding-Geng Chen, Shuyen Ho und Joseph C. Cappelleri
Mitwirkende
Autor / AutorinNaitee Ting
Autor / AutorinDing-Geng Chen
Autor / AutorinShuyen Ho
Autor / AutorinJoseph C. Cappelleri
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.